Total Payments
$369.16
2024 Payments
$50.32
Companies
5
Transactions
18
Medicare Patients
1,714
Medicare Billing
$136,821
Payment Breakdown by Category
Food & Beverage$369.16 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $369.16 | 18 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Horizon Therapeutics plc | $171.39 | 14 | $0 (2023) |
| Allergan, Inc. | $125.00 | 1 | $0 (2021) |
| ABBVIE INC. | $25.85 | 1 | $0 (2024) |
| Amgen Inc. | $24.47 | 1 | $0 (2024) |
| Alcon Vision LLC | $22.45 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $50.32 | 2 | ABBVIE INC. ($25.85) |
| 2023 | $145.65 | 13 | Horizon Therapeutics plc ($145.65) |
| 2021 | $150.74 | 2 | Allergan, Inc. ($125.00) |
| 2019 | $22.45 | 1 | Alcon Vision LLC ($22.45) |
All Payment Transactions
18 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/15/2024 | Amgen Inc. | UPLIZNA (Biological) | Food and Beverage | In-kind items and services | $24.47 | General |
| Category: Inflammation/Rare Disease | ||||||
| 03/29/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $25.85 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 12/20/2023 | Horizon Therapeutics plc | TEPEZZA (Drug) | Food and Beverage | In-kind items and services | $9.77 | General |
| Category: TEPEZZA | ||||||
| 12/06/2023 | Horizon Therapeutics plc | TEPEZZA (Drug) | Food and Beverage | In-kind items and services | $43.76 | General |
| Category: TEPEZZA | ||||||
| 11/20/2023 | Horizon Therapeutics plc | TEPEZZA (Drug) | Food and Beverage | In-kind items and services | $8.63 | General |
| Category: TEPEZZA | ||||||
| 10/24/2023 | Horizon Therapeutics plc | TEPEZZA (Drug) | Food and Beverage | In-kind items and services | $9.51 | General |
| Category: TEPEZZA | ||||||
| 09/20/2023 | Horizon Therapeutics plc | TEPEZZA (Drug) | Food and Beverage | In-kind items and services | $8.13 | General |
| Category: TEPEZZA | ||||||
| 07/31/2023 | Horizon Therapeutics plc | TEPEZZA (Drug) | Food and Beverage | In-kind items and services | $7.97 | General |
| Category: TEPEZZA | ||||||
| 06/28/2023 | Horizon Therapeutics plc | TEPEZZA (Drug) | Food and Beverage | In-kind items and services | $8.45 | General |
| Category: TEPEZZA | ||||||
| 05/31/2023 | Horizon Therapeutics plc | TEPEZZA (Drug) | Food and Beverage | In-kind items and services | $7.67 | General |
| Category: TEPEZZA | ||||||
| 05/04/2023 | Horizon Therapeutics plc | TEPEZZA (Drug) | Food and Beverage | In-kind items and services | $7.19 | General |
| Category: TEPEZZA | ||||||
| 04/11/2023 | Horizon Therapeutics plc | TEPEZZA (Drug) | Food and Beverage | In-kind items and services | $6.51 | General |
| Category: TEPEZZA | ||||||
| 03/20/2023 | Horizon Therapeutics plc | TEPEZZA (Drug) | Food and Beverage | In-kind items and services | $9.41 | General |
| Category: TEPEZZA | ||||||
| 01/31/2023 | Horizon Therapeutics plc | TEPEZZA (Drug) | Food and Beverage | In-kind items and services | $8.63 | General |
| Category: TEPEZZA | ||||||
| 01/18/2023 | Horizon Therapeutics plc | TEPEZZA (Drug) | Food and Beverage | In-kind items and services | $10.02 | General |
| Category: TEPEZZA | ||||||
| 10/04/2021 | Horizon Therapeutics plc | TEPEZZA (Drug) | Food and Beverage | In-kind items and services | $25.74 | General |
| Category: TEPEZZA | ||||||
| 05/27/2021 | Allergan, Inc. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: GLAUCOMA | ||||||
| 02/13/2019 | Alcon Vision LLC | AcrySof (Device) | Food and Beverage | In-kind items and services | $22.45 | General |
| Category: Ophthalmology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 273 | 320 | $78,345 | $19,854 |
| 2022 | 9 | 463 | 583 | $147,890 | $37,253 |
| 2021 | 11 | 495 | 607 | $155,790 | $41,940 |
| 2020 | 11 | 483 | 565 | $158,465 | $37,774 |
Total Patients
1,714
Total Services
2,075
Medicare Billing
$136,821
Procedure Codes
37
All Medicare Procedures & Services
37 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 59 | 75 | $24,000 | $7,281 | 30.3% |
| 92083 | Exam of visual field with extended testing | Office | 2023 | 71 | 83 | $22,410 | $4,198 | 18.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 26 | 28 | $11,900 | $3,825 | 32.1% |
| 92134 | Imaging of retina | Office | 2023 | 61 | 69 | $9,660 | $2,097 | 21.7% |
| 92133 | Imaging of optic nerve | Office | 2023 | 40 | 48 | $6,720 | $1,337 | 19.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 16 | 17 | $3,655 | $1,116 | 30.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 101 | 147 | $47,040 | $13,976 | 29.7% |
| 92083 | Exam of visual field with extended testing | Office | 2022 | 102 | 121 | $32,670 | $6,023 | 18.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 42 | 45 | $19,125 | $5,898 | 30.8% |
| 92133 | Imaging of optic nerve | Office | 2022 | 116 | 157 | $21,930 | $4,338 | 19.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 13 | 13 | $7,865 | $2,213 | 28.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 14 | 14 | $6,790 | $1,619 | 23.9% |
| 92134 | Imaging of retina | Office | 2022 | 43 | 48 | $6,720 | $1,503 | 22.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 13 | 16 | $3,440 | $1,081 | 31.4% |
| G2212 | Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 2022 | 19 | 22 | $2,310 | $601.08 | 26.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 74 | 109 | $34,880 | $10,714 | 30.7% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 54 | 57 | $24,225 | $8,466 | 34.9% |
| 92083 | Measurement of field of vision during daylight conditions, extended examination | Office | 2021 | 109 | 115 | $31,050 | $6,123 | 19.7% |
| 92133 | Diagnostic imaging of optic nerve of eye | Office | 2021 | 118 | 166 | $23,240 | $4,873 | 21.0% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 23 | 23 | $13,915 | $4,159 | 29.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 25 | 35 | $7,525 | $2,497 | 33.2% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 14 | 14 | $6,790 | $1,807 | 26.6% |
| 92060 | Measurement of eye muscles to detect deviation of eyeball | Office | 2021 | 22 | 29 | $5,510 | $1,493 | 27.1% |
| 92134 | Diagnostic imaging of retina | Office | 2021 | 23 | 24 | $3,360 | $807.33 | 24.0% |
| G2212 | Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 2021 | 21 | 23 | $2,415 | $646.28 | 26.8% |
About Eman Hawy
Eman Hawy is a Neuro-ophthalmology healthcare provider based in Loma Linda, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/05/2014. The National Provider Identifier (NPI) number assigned to this provider is 1871911917.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Eman Hawy has received a total of $369.16 in payments from pharmaceutical and medical device companies, with $50.32 received in 2024. These payments were reported across 18 transactions from 5 companies. The most common payment nature is "Food and Beverage" ($369.16).
As a Medicare-enrolled provider, Hawy has provided services to 1,714 Medicare beneficiaries, totaling 2,075 services with total Medicare billing of $136,821. Data is available for 4 years (2020–2023), covering 37 distinct procedure/service records.
Ad
Practice Information
- Specialty Neuro-ophthalmology
- Other Specialties Neuro-ophthalmology, Neurology
- Location Loma Linda, CA
- Active Since 04/05/2014
- Last Updated 06/22/2020
- Taxonomy Code 207WX0109X
- Entity Type Individual
- NPI Number 1871911917
Products in Payments
- TEPEZZA (Drug) $171.39
- DURYSTA (Drug) $125.00
- BOTOX (Biological) $25.85
- UPLIZNA (Biological) $24.47
- AcrySof (Device) $22.45
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.